-
1 Comment
Inspire Medical Systems, Inc is currently in a long term downtrend where the price is trading 2.5% below its 200 day moving average.
From a valuation standpoint, the stock is 96.5% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 46.3.
Inspire Medical Systems, Inc's total revenue rose by 71.0% to $46M since the same quarter in the previous year.
Its net income has increased by 17.6% to $-7M since the same quarter in the previous year.
Finally, its free cash flow grew by 27.7% to $-5M since the same quarter in the previous year.
Based on the above factors, Inspire Medical Systems, Inc gets an overall score of 4/5.
Industry | Medical Devices |
---|---|
Sector | Healthcare |
ISIN | US4577301090 |
CurrencyCode | USD |
Exchange | NYSE |
Target Price | 306.3 |
---|---|
PE Ratio | None |
Market Cap | 7B |
Beta | 1.46 |
Dividend Yield | 0.0% |
Inspire Medical Systems, Inc., a medical technology company, focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA) in the United States and internationally. The company offers Inspire system, a neurostimulation technology that provides a safe and effective treatment for moderate to severe OSA. It also develops a novel, a closed-loop solution that continuously monitors a patient's breathing and delivers mild hypoglossal nerve stimulation to maintain an open airway. The company was incorporated in 2007 and is headquartered in Golden Valley, Minnesota.
Learn MoreHere's how to backtest a trading strategy or backtest a portfolio for INSP using our backtest tool. PyInvesting provides the backtesting software for you to backtest your investment strategy. Our backtest software is written using Python code and allows you to backtest stock, backtest etf, backtest options, backtest crypto and backtest forex online. Our backtesting Python framework is highly robust and gives you a realistic simulation of how your strategy would have performed in the past using backtest data.
© PyInvesting 2024